Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological therapies, adult, Research, artificial intelligence (AI), Lymphoid Leukemias, ALL, Non-Biological therapies, Clinical Research, Chemotherapy, Combination therapy, pediatric, Diseases, Therapies, therapy sequence, Adverse Events, Lymphoid Malignancies, registries, Technology and Procedures, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Biological therapies, adult, Research, artificial intelligence (AI), Lymphoid Leukemias, ALL, Non-Biological therapies, Clinical Research, Chemotherapy, Combination therapy, pediatric, Diseases, Therapies, therapy sequence, Adverse Events, Lymphoid Malignancies, registries, Technology and Procedures, Study Population, Human, Transplantation
Saturday, December 10, 2022: 4:00 PM-5:30 PM
343-345
(Ernest N. Morial Convention Center)
Moderators:
Boglarka Gyurkocza, MD, Memorial Sloan Kettering Cancer Center
and
Shernan G Holtan, MD, University of Minnesota
Disclosures:
Gyurkocza: Actinium Pharmaceuticals, Inc.: Research Funding. Holtan: CSL Behring: Other: Clinical trial adjudication; Vitrac Therapeutics: Research Funding; Incyte: Research Funding.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH